Direct transmission of highly pathogenic avian influenza (HPAI) viruses to humans was not considered a major risk prior to 1997. In 1997, however, H5N1 HPAI viruses were transmitted to humans in Hong Kong. Six of 18 infected individuals died, marking the first fatal infection of humans with wholly avian influenza viruses (Claas et al., 1998a,b; Subbarao & Shaw, 2000). Since then, H5N1 HPAI viruses have spread throughout southeast Asia and recently into Europe and Africa. To date, more than 200 individuals have been infected and about half have succumbed to the infection (World Health Organization, 2006). Despite the continued transmission of H5N1 HPAI viruses to humans, these viruses have not yet acquired the ability to spread efficiently among humans. Here, we discuss the factors that lead to human infections with H5N1 HPAI viruses as they relate to the binding of the virus to its cellular receptor.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Amonsin, A., Payungporn, S., Theamboonlers, A., Thanawongnuwech, R., Suradhat, S., Pariyothorn, N., Tantilertcharoen, R., Damrongwantanapokin, S., Buranathai, C., Chaisingh, A., Songserm, T., & Poovorawan, Y. (2006). Genetic characterization of H5N1 influenza A viruses isolated from zoo tigers in Thailand. Virology, 344, 480–491.
Baum, L.G., & Paulson, J.C. (1990). Sialyloligosaccharides of the respiratory epithelium in the selection of human influenza virus receptor specificity. Acta Histochem., 40, 35–38.
Butler, D. (2006a). Alarms ring over bird flu mutations. Nature, 439, 248–249.
Butler, D. (2006b). Family tragedy spotlights flu mutations. Nature, 442, 114–115.
Claas, E.C., de Jong, D.C., van Reek, B.R., Rimmelzwaan, G.F., & Osterhaus, A.D. (1998a). Human influenza virus A/HongKong/156/97 (H5N1) infection. Vaccine, 16, 977–978.
Claas, E.C., Osterhaus, A.D., van Reek, B.R., De Jong, J.C., Rimmelzwaan, G.F., Senne, D.A., Krauss, S., Shortridge, K.F., & Webster, R.G. (1998b). Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet, 351, 472–477.
Connor, R.J., Kawaoka, Y., Webster, R.G., & Paulson, J.C. (1994). Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology, 205, 17–23.
Duksin, D., & Bornstein, P. (1977). Changes in surface properties of normal and transformed cells caused by tunicamycin, an inhibitor of protein glycosylation. Proc. Natl Acad. Sci. U. S. A., 74, 3433–3437.
Fouchier, R.A., Schneeberger, P.M., Rozendaal, F.W., Broekman, J.M., Kemink, S.A., Munster, V., Kuiken, T., Rimmelzwaan, G.F., Schutten, M., Van Doornum, G.J., Koch, G., Bosman, A., Koopmans, M., & Osterhaus, A.D. (2004). Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc. Natl Acad. Sci. U. S. A., 101, 1356–1361.
Gambaryan, A., Tuzikov, A., Pazynina, G., Bovin, N., Balish, A., & Klimov, A. (2006). Evolution of the receptor binding phenotype of influenza A (H5) viruses. Virology, 344, 432–438.
Gu, J., & Taniguchi, N. (2004). Regulation of integrin functions by N-glycans. Glycoconj. J., 21, 9–15.
Hatta, M., Gao, P., Halfmann, P., & Kawaoka, Y. (2001). Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science, 293, 1840–1842.
Hinshaw, V.S., Webster, R.G., Naeve, C.W., & Murphy, B.R. (1983). Altered tissue tropism of human-avian reassortant influenza viruses. Virology, 128, 260–263.
Irie, A., Koyama, S., Kozutsumi, Y., Kawasaki, T., & Suzuki, A. (1998). The molecular basis for the absence of N-glycolylneuraminic acid in humans. J. Biol. Chem., 273, 15866–15871.
Ito, T., Suzuki, Y., Suzuki, T., Takada, A., Horimoto, T., Wells, K., Kida, H., Otsuki, K., Kiso, M., Ishida, H., & Kawaoka, Y. (2000). Recognition of N-glycolylneuraminic acid linked to galactose by the alpha2, 3 linkage is associated with intestinal replication of influenza A virus in ducks. J. Virol., 74, 9300–9305.
Iwatsuki-Horimoto, K., Kanazawa, R., Sugii, S., Kawaoka, Y., & Horimoto, T. (2004). The index influenza A virus subtype H5N1 isolated from a human in 1997 differs in its receptor-binding properties from a virulent avian influenza virus. J. Gen. Virol., 85, 1001–1005.
Kobasa, D., Takada, A., Shinya, K., Hatta, M., Halfmann, P., Theriault, S., Suzuki, H., Nishimura, H., Mitamura, K., Sugaya, N., Usui, T., Murata, T., Maeda, Y., Watanabe, S., Suresh, M., Suzuki, T., Suzuki, Y., Feldmann, H., & Kawaoka, Y. (2004). Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature, 431, 703–707.
Le, Q.M., Kiso, M., Someya, K., Sakai, Y.T., Nguyen, T.H., Nguyen, K.H., Pham, N.D., Ngyen, H.H., Yamada, S., Muramoto, Y., Horimoto, T., Takada, A., Goto, H., Suzuki, T., Suzuki, Y., & Kawaoka, Y. (2005). Avian flu: Isolation of drug-resistant H5N1 virus. Nature, 437, 1108.
Lin, A.H., & Cannon, P.M. (2002). Use of pseudotyped retroviral vectors to analyze the receptor-binding pocket of hemagglutinin from a pathogenic avian influenza A virus (H7 subtype). Virus Res., 83, 43–56.
Matrosovich, M.N., Gambaryan, A.S., Tuzikov, A.B., Byramova, N.E., Mochalova, L.V., Golbraikh, A.A., Shenderovich, M.D., Finne, J., & Bovin, N.V. (1993). Probing of the receptor-binding sites of the H1 and H3 influenza A and influenza B virus hemagglutinins by synthetic and natural sialosides. Virology, 196, 111–121.
Matrosovich, M., Zhou, N., Kawaoka, Y., & Webster, R. (1999). The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. J. Virol., 73, 1146–1155.
Matrosovich, M., Tuzikov, A., Bovin, N., Gambaryan, A., Klimov, A., Castrucci, M.R., Donatelli, I., & Kawaoka, Y. (2000). Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J. Virol., 74, 8502–8512.
Matrosovich, M.N., Matrosovich, T.Y., Gray, T., Roberts, N.A., & Klenk, H.D. (2004). Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc. Natl Acad. Sci. U. S. A., 101, 4620–4624.
Naffakh, N., Massin, P., Escriou, N., Crescenzo-Chaigne, B., & van der Werf, S. (2000). Genetic analysis of the compatibility between polymerase proteins from human and avian strains of influenza A viruses. J. Gen. Virol., 81, 1283–1291.
Reed, B.C., Ronnett, G.V., & Lane, M.D. (1981). Role of glycosylation and protein synthesis in insulin receptor metabolism by 3T3–L1 mouse adipocytes. Proc. Natl Acad. Sci. U. S. A., 78, 2908–2912.
Rogers, G.N., & Paulson, J.C. (1983). Receptor determinants of human and animal influenza virus isolates: Differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology, 127, 361–373.
Rogers, G.N., Paulson, J.C., Daniels, R.S., Skehel, J.J., Wilson, I.A., & Wiley, D.C. (1983). Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature, 304, 76–78.
Rougon, G., Deagostini-Bazin, H., Hirn, M., & Goridis, C. (1982). Tissue- and developmental stage-specific forms of a neural cell surface antigen linked to differences in glycosylation of a common polypeptide. EMBO J., 1, 1239–1244.
Ryan-Poirier, K., Suzuki, Y., Bean, W.J., Kobasa, D., Takada, A., Ito, T., & Kawaoka, Y. (1998). Changes in H3 influenza A virus receptor specificity during replication in humans. Virus Res., 56, 169–176.
Schauer, R. (2000). Achievements and challenges of sialic acid research. Glycoconj. J., 17, 485–499.
Shinya, K., Hatta, M., Yamada, S., Takada, A., Watanabe, S., Halfmann, P., Horimoto, T., Neumann, G., Kim, J.H., Lim, W., Guan, Y., Peiris, M., Kiso, M., Suzuki, T., Suzuki, Y., & Kawaoka, Y. (2005). Characterization of a human H5N1 influenza A virus isolated in 2003. J. Virol., 79, 9926–9932.
Shinya, K., Ebina, M., Yamada, S., Ono, M., Kasai, N., & Kawaoka, Y. (2006). Avian flu: Influenza virus receptors in the human airway. Nature, 440, 435–436.
Stevens, J., Corper, A.L., Basler, C.F., Taubenberger, J.K., Palese, P., & Wilson, I.A. (2004). Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science, 303, 1866–1870.
Stevens, J., Blixt, O., Tumpey, T.M., Taubenberger, J.K., Paulson, J.C., & Wilson, I.A. (2006). Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science, 312, 404–410.
Subbarao, K., & Shaw, M.W. (2000). Molecular aspects of avian influenza (H5N1) viruses isolated from humans. Rev. Med. Virol., 10, 337–348.
Subbarao, K., Klimov, A., Katz, J., Regnery, H., Lim, W., Hall, H., Perdue, M., Swayne, D., Bender, C., Huang, J., Hemphill, M., Rowe, T., Shaw, M., Xu, X., Fukuda, K., & Cox, N. (1998). Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science, 279, 393–396.
Suzuki, Y. (2005). Sialobiology of influenza: Molecular mechanism of host range variation of influenza viruses. Biol. Pharm. Bull., 28, 399–408.
Suzuki, Y., Ito, T., Suzuki, T., Holland Jr., R.E., Chambers, T.M., Kiso, M., Ishida, H., & Kawaoka, Y. (2000). Sialic acid species as a determinant of the host range of influenza A viruses. J. Virol., 74, 11825–11831.
Uiprasertkul, M., Puthavathana, P., Sangsiriwut, K., Pooruk, P., Srisook, K., Peiris, M., Nicholls, J.M., Chokephaibulkit, K., Vanprapar, N., & Auewarakul, P. (2005). Influenza A H5N1 replication sites in humans. Emerg. Infect. Dis., 11, 1036–1041.
Ungchusak, K., Auewarakul, P., Dowell, S.F., Kitphati, R., Auwanit, W., Puthavathana, P., Uiprasertkul, M., Boonnak, K., Pittayawonganon, C., Cox, N.J., Zaki, S.R., Thawatsupha, P., Chittaganpitch, M., Khontong, R., Simmerman, J.M., & Chunsutthiwat, S. (2005). Probable person-to-person transmission of avian influenza A (H5N1). N. Engl. J. Med., 352, 333–340.
van Riel, D., Munster, V.J., de Wit, E., Rimmelzwaan, G.F., Fouchier, R.A., Osterhaus, A.D., & Kuiken, T. (2006). H5N1 virus attachment to lower respiratory tract. Science, 312, 399.
World Health Organization. (2006). Epidemiology of WHO-confirmed human cases of avian influenza A(H5N1) infection. Wkly. Epidemiol. Rec., 81, 249–257.
Yamada, S., Suzuki, Y., Suzuki, T., Le, M.Q., Nidom, C.A., Sakai-Tagawa, Y., Muramoto, Y., Ito, M., Kiso, M., Horimoto, T., Shinya, K., Sawada, T., Kiso, M., Usui, T., Murata, T., Lin, Y., Hay, A., Haire, L.F., Stevens, D.J., Russell, R.J., Gamblin, S.J., Skehel, J.J., & Kawaoka, Y. (2006). Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature, 444, 378–382.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Kawaoka, Y., Shinya, K. (2008). Transmission of Avian Influenza Viruses to Humans: Viral Receptor Specificity and Distribution in Human Airways. In: Lu, Y., Essex, M., Roberts, B. (eds) Emerging Infections in Asia. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-75722-3_3
Download citation
DOI: https://doi.org/10.1007/978-0-387-75722-3_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-75721-6
Online ISBN: 978-0-387-75722-3
eBook Packages: MedicineMedicine (R0)